Page last updated: 2024-11-02

pentobarbital and Dementia

pentobarbital has been researched along with Dementia in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CRISP, GO1
SUZUKI, K1
KOREY, SR1
TERRY, RD1

Other Studies

2 other studies available for pentobarbital and Dementia

ArticleYear
A NEW LOOK AT PENTOBARBITAL.
    Western medicine; the medical journal of the west, 1964, Volume: 5

    Topics: Anxiety; Anxiety Disorders; Dementia; Female; Heart Diseases; Humans; Hypertension; Menopause; Neuro

1964
STUDIES ON PROTEIN SYNTHESIS IN BRAIN MICROSOMAL SYSTEM.
    Journal of neurochemistry, 1964, Volume: 11

    Topics: Amino Acids; Biomedical Research; Brain; Brain Diseases; Brain Neoplasms; Dementia; Electrons; Ether

1964